The patient or a legally authorized representative must provide study-specific informed consent prior to step  registration
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry.
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
Patients or their legally authorized representative must provide written informed consent
Documented informed consent of participant and/or legally authorized representative
Must sign study-specific, IRB approved informed consent form prior to study entry. Note consent by legally authorized representative is not allowed for this trial.
The participant (or legally authorized representative, if applicable) must be willing and able to provide written informed consent for the trial
Documented informed consent of participant and/or legally authorized representative
The patient or legally authorized representative must provide study-specific informed consent prior to study entry
Documented informed consent of the participant or legally authorized representative
Patient must have the ability to understand the requirements of the study and signed informed consent. A signed informed consent by the patient or his legally authorized representative is required\r\nprior to their enrollment on the protocol
Patients or their legally authorized representative must provide written informed consent
Documented informed consent of the participant and/or legally authorized representative
Documented informed consent of the subject and/or legally authorized representative
Patients or their legally authorized representative must provide written informed consent
Able to understand the potential risks, benefits, and requirements of the study and are willing to provide informed consent; an informed consent form for this study that is signed by the patient or his/her legally authorized representative is required prior to enrollment
Able to understand the potential risks, benefits, and requirements of the study and are willing to provide informed consent; an informed consent form for this study that is signed by the patient or his/her legally authorized representative is required prior to enrollment
Patients or their legally authorized representative must provide written informed consent
Patients or their legally authorized representative must have the ability to understand and provide signed informed written consent
Patients or their legally authorized representative must provide written informed consent
Patients or their legally authorized representative must provide written informed consent
Patients or their legally authorized representative must provide written informed consent
Patients or their legally authorized representative must provide written informed consent
Patients or their legally authorized representative must provide written informed consent
Patient or legally authorized representative able to sign informed consent
Patients or their legally authorized representative must provide written informed consent
Patient, legally authorized representative (LAR), or parent able to sign informed consent; able to give assent for patients age -
Patient must have the ability to understand the requirements of the study and signed informed consent a signed informed consent by the patient or his legally authorized representative is required prior to their enrollment on the protocol
Patient or legally authorized representative able to sign informed consent
Must sign study-specific, IRB approved informed consent form prior to study entry. Note consent by legally authorized representative is not allowed for this trial.
Patient or legally authorized representative able to sign informed consent
Patient must have the ability to understand the requirements of the study and signed informed consent; a signed informed consent by the patient or his legally authorized representative is required prior to their enrollment on the protocol
Patient must have the ability to understand the requirements of the study and signed informed consent; a signed informed consent by the patient or his legally authorized representative is required prior to their enrollment on the protocol
Signed informed consent by the patient or legally authorized representative
Voluntary written consent (adult or legally authorized representative; or parental/guardian)
Cases involving subjects who are minors, pregnant or require an authorized representative for informed consent
Documented informed consent of the participant and/or the legally authorized representative
Documented informed consent of the participant and/or legally authorized representative
Patient or legally authorized representative able to sign informed consent
Patient must have the ability to understand the requirements of the study and signed informed consent; a signed informed consent by the patient or his legally authorized representative is required prior to their enrollment on the protocol
The patient or a legally authorized representative must provide study-specific informed consent prior to study registration
The patient or a legally authorized representative must provide study-specific informed consent prior to step  registration
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry, including consent for mandatory tumor tissue, serum, and blood submission for immune correlatives (all patients) and p analysis (oropharyngeal cases only)
The patient or a legally authorized representative must provide study-specific informed consent prior to step  registration
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
Subject or Authorized Representative is unable to provide informed consent.
Patients or their legally authorized representative must provide written informed consent
Be willing and able to provide written informed consent/assent for the trial; consent may be obtained by legally authorized representative (LAR) according to the protocol
Patients or their legally authorized representative must provide written informed consent
Patients or their legally authorized representative must provide written informed consent
Either the subject or his/her legally authorized representative be willing and able to provide written informed consent for the trial
Written informed consent, Release of Medical Records Form and HIPAA reviewed and signed by patient or legally authorized representatives
The patient must be willing and able to comply with all study protocol requirements. The patient or a legally authorized representative must fully understand all elements of the informed consent and have signed the informed consent according to institutional and federal regulatory requirements
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
Able to give informed consent, or their legally authorized representative can give informed consent
Patient, or his/her legally authorized representative, is able to understand and provide informed consent.
Patient or a legally authorized representative of a patient must be able and willing to sign informed consent document that has been approved by an IRB
Patients or their legally authorized representative must provide written informed consent
A written and voluntarily signed informed consent must be obtained from the patient or legally authorized representative, in accordance with local regulations, before the initiation of any study related procedures. The patient or legally authorized representative must be able to read and understand the informed consent form (ICF).
Patient or legally authorized representative able to sign an informed consent form
Patient or legally authorized representative able to sign informed consent
A written and voluntarily signed informed consent must be obtained from the patient or legally authorized representative, in accordance with local regulations, before the initiation of any study related procedures. The patient or legally authorized representative must be able to read and understand the informed consent form (ICF).
Documented informed consent of the participant and/or legally authorized representative
Patients or their legally authorized representative must provide written informed consent
Able to provide informed consent, or if the oncology physician determines the patient to not have decision-making capacity, a patient-designated health care proxy (or authorized representative per institutional policies) must sign consent by the baseline visit; if the participant is found to be impaired on the Blessed-Orientation Memory Concentration Test (BOMC) during screening; they must have a health care proxy or authorized representative to be eligible to enroll
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
Ability to understand and/or the willingness of the patient (or parent or legally authorized representative, if minor) to provide informed consent, using an institutionally approved informed consent procedure
Documented informed consent of the participant and/or legally authorized representative
Legally authorized representative consent
Subject or authorized representative has provided informed consent.
Participant/parent/legally authorized representative (LAR) unwilling to give written informed consent
Decisionally impaired adults requiring a legally authorized representative
Voluntary written consent signed by the subject (or the subjects legally authorized representative)
Subject or legally authorized representative signs study-related informed consent document
Patient or the patients legally authorized representative must provide written informed consent prior to registration and any study-related procedures
Valid informed consent by subject or subjects legally authorized representative (LAR)
Patient, or authorized representative signs a written Informed Consent form to participate in the study, prior to any study mandated determinations or procedure
Patient, or authorized representative signs a written Informed Consent form to participate in the study, prior to any study mandated determinations or procedure
